Janney Montgomery Scott Defends DepoMed (DEPO) Amid Downgrade-Related Weakness
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/21/2026
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Walmart shares fall despite earnings beat
- Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Moderna stock pulls back after massive one-day rally: analysts weigh in
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Supermicro probe finds no senior management link to export violations
- SpaceX shares fall as second lockup period ends
- Hertz Global amends voting agreement with CK Amarillo after lawsuit
UBS Downgrades DepoMed Inc (DEPO) to Neutral
July 7, 2016 7:23 AM EDTUBS downgraded DepoMed Inc (NASDAQ: DEPO) from Buy to Neutral with a price target of $20.00.
Analyst Ami Fadia cited:
(1) We see risk to mgt's 2016 sales guidance of $490-520M and consensus of $495M as the base business has underperformed our... More
